<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01129687</url>
  </required_header>
  <id_info>
    <org_study_id>SU-03052010-5142</org_study_id>
    <nct_id>NCT01129687</nct_id>
  </id_info>
  <brief_title>Subtotal Resection of Large Acoustic Neuromas With Possible Stereotactic Radiation Therapy</brief_title>
  <official_title>Multicenter Prospective Analysis of Treatment Outcome in Patients With Large Acoustic Neuromas</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Cincinnati</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Baylor College of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Weill Medical College of Cornell University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Iowa</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Texas</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>George Washington University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Indiana University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Louisiana State University Health Sciences Center in New Orleans</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Stanford University</source>
  <brief_summary>
    <textblock>
      The investigators study is to investigate safety and efficacy of performing a planned
      incomplete removal of large acoustic neuroma tumors to decrease surgical morbidity and yet
      avoid tumor recurrence by post-operative radiation therapy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The current standard treatment of a large tumor of the balance nerve (acoustic neuroma or
      vestibular schwannoma) is surgical resection. Complete removal of such tumor is associated
      with significant risks of hearing loss and facial paralysis whereas incomplete removal of the
      tumor is associated with significant risks of regrowth. Stereotactic radiation is a well
      accepted therapy aiming at stopping the growth of smaller acoustic neuromas before their
      sizes become large enough to cause problems. The purpose of our study is to determine whether
      the combination of subtotal resection followed by stereotactic radiation of the remnant can
      control large acoustic neuromas without the significant risks associated with complete
      resection.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2005</start_date>
  <completion_date type="Anticipated">March 2025</completion_date>
  <primary_completion_date type="Anticipated">March 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Need for stereotactic radiation therapy should tumor remnant grow on annual MRI's</measure>
    <time_frame>10 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Facial nerve function measured on House-Brackmann scale</measure>
    <time_frame>10 y</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Neuroma, Acoustic</condition>
  <arm_group>
    <arm_group_label>ANSRS group</arm_group_label>
    <description>Patients qualifying for the study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Microsurgery</intervention_name>
    <description>Patient would under to total, near-total, or subtotal resection of tumor</description>
    <arm_group_label>ANSRS group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Stereotactic radiation therapy</intervention_name>
    <description>Patient who has sign of growth of tumor remnant would undergo this treatment</description>
    <arm_group_label>ANSRS group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with large acoustic neuromas measuring 2.5cm in longest dimension in the
        cerebellopontine angle.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients with acoustic neuromas the widest diameter of 2.5 cm or larger at the
             cerebellopontine angle are eligible for this trial.

          -  Patients that are deemed good surgical candidates based on age, general health,
             genetic predispositions, and hearing in contralateral side would be included as the
             subjects of this trial.

          -  Although we would include patients with neurofibromatosis II in this trial,
             considering their genetic predisposition for recurrence, we would analyze their
             outcome as a separate group.

        Exclusion Criteria:

          -  Patients who have received any form of treatment of their acoustic neuromas prior to
             enrollment in the study including surgery or radiation therapy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ashkan Monfared, MD</last_name>
    <role>Study Director</role>
    <affiliation>George Washington University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Robert K Jackler, MD</last_name>
    <role>Study Director</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>ashkan monfared, MD</last_name>
    <phone>(202)741-3250</phone>
    <email>monfared@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Stanford University School of Medicine</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ashkan monfared, MD</last_name>
      <phone>202-741-3250</phone>
      <email>monfared@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Dr Robert Jackler</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ashkan Monfared</last_name>
      <role>Study Director</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>George Washington University</name>
      <address>
        <city>Washington, D.C.</city>
        <state>District of Columbia</state>
        <zip>20037</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashkan Monfared, MD</last_name>
      <phone>202-741-3017</phone>
      <email>monfared@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Shelly Greene</last_name>
      <phone>202-741-3450</phone>
      <email>sgreene@mfa.gwu.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Ashkan Monfared, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Indiana University</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Terese Stevens</last_name>
      <phone>317-278-1255</phone>
      <email>tstevens@iupui.edu</email>
    </contact>
    <investigator>
      <last_name>Rick Nelson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Iowa</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marlan Hansen, MD</last_name>
      <phone>319-353-7151</phone>
      <email>marlan-hansen@uiowa.edu</email>
    </contact>
    <investigator>
      <last_name>Marlan Hansen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Louisiana State University</name>
      <address>
        <city>Baton Rouge</city>
        <state>Louisiana</state>
        <zip>70808</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Therese Demouy, MD</last_name>
      <phone>225-765-6833</phone>
      <email>Therese.Demouy@ololrmc.com</email>
    </contact>
    <contact_backup>
      <last_name>Moises Arriaga, MD</last_name>
      <phone>(504) 568-3779</phone>
      <email>maa@neurotologic.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Weill Cornell Medical College</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Teresa Valderrama, MPH</last_name>
      <phone>646-962-5399</phone>
      <email>tev2002@med.cornell.edu</email>
    </contact>
    <investigator>
      <last_name>Samuel Selesnick</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Cincinnati</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Texas Southwestern</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Bryan</last_name>
      <phone>214-648-2913</phone>
      <email>Anna.Bryan@utsouthwestern.edu</email>
    </contact>
    <contact_backup>
      <last_name>Walter Kutz, MD</last_name>
      <phone>214-648-2432</phone>
      <email>Walter.Kutz@utsouthwestern.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Walter Kutz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baylor College of Medicine</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 10, 2010</study_first_submitted>
  <study_first_submitted_qc>May 24, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 25, 2010</study_first_posted>
  <last_update_submitted>April 24, 2017</last_update_submitted>
  <last_update_submitted_qc>April 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>George Washington University</investigator_affiliation>
    <investigator_full_name>Ashkan Monfared</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neuroma</mesh_term>
    <mesh_term>Neuroma, Acoustic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

